Search
News
Novel Tricuspid and Mitral Valve Procedures Improve Patients' Quality of Life
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.
News
Chances of Receiving Percutaneous Coronary Intervention in a Low-Volume Facility are Increasing, Despite Worse Outcomes
There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes.
News
How the Cardiogenic Shock Team Improves Patient Outcomes at UCSF
A 69-year-old woman with heart failure with reduced ejection fraction caused by left ventricular noncompaction (LVNC) came to the UCSF emergency department with tachycardia, dizziness, shortness of breath and swelling, despite taking all prescribed heart failure medications.
News
UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.
News
Ross Procedure the Right Choice for Active Patient With Aortic Stenosis
A 52-year-old man with severe aortic stenosis chose to undergo a Ross procedure at UCSF during which surgeons replaced his diseased aortic valve with his own pulmonary valve. He was discharged within a week and is recovering well.
News
Structural Heart Disease Expert Leads UCSF Interventional Cardiology Program
Sammy Elmariah, MD, MPH, has joined UCSF as chief of the Interventional Cardiology Program and medical director of the cardiac catheterization lab.
Video
Don’t Miss a Beat on A-fib: How to Make the Right Plans for Individual Patients
This practical, data-fueled talk from Edward P. Gerstenfeld, MD, MS, FACC, chief of the UCSF Cardiac Electrophysiology and Arrhythmia Service, will help PCPs better understand how to assess stroke risk; make treatment decisions...
Document
Cardiology Transfer Guide
Cardiology Transfer Guide
Document
UCSF Health Transfer Center Intake Workflow
UCSF Health Transfer Center Intake Workflow
News
UCSF Researchers Develop Prediction Model of Aortic Aneurysm
Ascending thoracic aortic disease is an important cause of sudden death in the U.S., yet most aortic aneurysms are identified incidentally.
Document
Advanced Heart Failure Comprehensive Care Center Physician Pocket Card
Referral guide and contact information for advanced heart failure specialists at UCSF.
News
UCSF Sheds Light on the Reasons Behind Sex Differences in Myocarditis
This study suggests mechanisms behind why myocarditis associated with cancer immunotherapies may occur more frequently in female patients.
Document
Advanced Heart Failure Comprehensive Care Center
The Advanced Heart Failure Comprehensive Care Center (AHF CCC) at UCSF offers coordinated and comprehensive care for heart failure patients.
Video
Learning and Lowering Cardiovascular Risk: Effective, Efficient Strategies
This data-driven presentation from cardiologist Eveline Stock, MD, will give you a better grasp on how to identify an at-risk patient.
Video
Common Vascular Conditions: Simple Screening Rules and Better Treatment Tactics
Vascular surgeon Shant Vartanian, MD, presents an update on understanding and managing abdominal aortic aneurysms and peripheral artery disease – prevalent age-linked disorders with significant morbidity and mortality.
News
Physical Activity May Still Not Match Pre-Covid 19 Pandemic Levels
Step counts—a measure of physical activity—were markedly lower early in the COVID-19 pandemic than pre-pandemic and remained lower, on average, in the two years following the onset of the global pandemic.
News
Prominent Cardiac Surgeons Join UCSF’s Advanced Heart Failure Comprehensive Care Center
UC San Francisco’s Cardiovascular team is welcoming two highly regarded cardiac surgeons to its renowned program. The specialists will join the newly formed Advanced Heart Failure Comprehensive Care Center (AHF CCC).
News
Airway Stenosis Study Focuses on Optimizing Patient Outcomes
UCSF researchers, in collaboration with colleagues at two other tertiary medical centers, determined that patients with multilevel airway stenosis (MLAS) have lower tracheostomy decannulation rates and require more surgeries than patients with posterior glottic stenosis (PGS).
News
Research Leads to New Myocarditis Diagnostic and Treatment Strategies
Research conducted by Javid Moslehi, MD, chief of the UCSF Cardio-Oncology and Immunology Program, has led to the discovery of a new form of myocarditis caused by immune checkpoint inhibitors (ICI).
Document
Electrophysiology and Arrhythmia Program
The UCSF Cardiac Electrophysiology and Arrhythmia Service is known worldwide for expert evaluation and treatment of patients with a variety of heart rhythm disorders.
Video
Keep Diabetic Patients on Their Feet: Keys to Identifying Limb-Threatening Issues
In a country where more than 9% of adults have diabetes, Alexander Reyzelman, DPM, discusses the implications for those who also have peripheral vascular disease.
News
Best Practices for Implementing Virtual and Hybrid Cardiac Rehabilitation Programs
In a new study, UCSF researchers found that patients participating in either virtual or hybrid cardiac rehabilitation (CR) programs showed similar improvements in functional capacity to those of in-person CR program participants. Hybrid programs combine in-person and virtual delivery.
News
Virtual Cardiac Rehabilitation Produces Similar Results as In-Person Treatment
UCSF Study Shows Potential Benefit of Expanding Availability for Patients Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers.
Video
Getting to the Heart of COVID: Do Infections or Vaccines Cause Cardiac Harm?
Cardiologist Clifton Watt, MD, offers new insights on the pathogenesis of heart problems resulting from COVID; breaks down the evidence on whether novel treatments – neutralizing antibodies and antivirals – have therapeutic or preventive value; then presents a risk-benefit analysis for the available vaccines, incorporating new data.
